Written by The South Korea Healthcare Cold Chain Logistics Market is expanding as demand for temperature-sensitive pharmaceuticals, vaccines, and biologics continues to increase. The market was valued at USD 117.5 million in 2024 and is projected to reach USD 292.4 million by 2035, registering a CAGR of 8.641% during 2025–2035. Growing healthcare infrastructure and stricter requirements for temperature-controlled transportation are supporting this development.
Vaccines, biopharmaceuticals, and clinical trial materials are among the key products requiring specialized logistics services. Maintaining appropriate temperature conditions throughout transportation and storage is essential for preserving product quality and efficacy. As the pharmaceutical and biotechnology sectors expand, demand for reliable cold chain infrastructure is expected to increase.
Technology is becoming an important part of cold chain operations in South Korea. IoT-based tracking systems and real-time temperature monitoring can help logistics providers identify temperature deviations and improve product traceability. Advanced refrigerated, frozen, and cryogenic solutions are also becoming increasingly important as healthcare products become more sophisticated.
The future outlook remains positive, supported by pharmaceutical growth, healthcare infrastructure investment, vaccine distribution, and increasing adoption of digital logistics technologies. Key companies profiled in the market include Samsung SDS, DHL Supply Chain, Geodis, Nippon Express, Kuehne + Nagel, FedEx, UPS, CJ Logistics, and DB Schenker.
Active Adult Community Market Size
Active Adult Community Market Share
Active Adult Community Market Trends